News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2020 Shelley Wood January 31, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2019 Shelley Wood December 31, 2019
News Features Year in Review: Physicians Pick the Biggest News of 2019 TCTMD News Team December 30, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Conference News AHA 2019 AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials Shelley Wood November 11, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2019 Todd Neale October 31, 2019
News Conference News ESC Heart Failure 2019 Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG Shelley Wood May 28, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Daily News NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field Shelley Wood November 02, 2018
News Conference News ESC 2018 New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All Michael O'Riordan August 29, 2018
News Daily News Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock? Caitlin E. Cox July 30, 2018
News Industry News BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina April 25, 2018
News Daily News Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure Todd Neale March 25, 2018
News Daily News Less Is Not Always More: Screening for Coronary Disease Underused in Patients With Heart Failure Todd Neale July 25, 2016
News Industry News CardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure April 19, 2016
News Industry News Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure October 27, 2015
News Daily News First-in-Man Study Demonstrates Safety, Feasibility of Adipose-Derived Cell Therapy for Heart Failure April 21, 2014
News Conference News Cell Therapy 2012 Novel Strategies Advance Cell Therapy for Cardiomyopathy February 05, 2012